Product
Naltrexone + Bupropion
2 clinical trials
2 indications
Indication
ObesityIndication
Type 2 DiabetesClinical trial
Behavioral and Pharmacological Treatments to Enhance Weight Outcomes After Metabolic and Bariatric SurgeryStatus: Recruiting, Estimated PCD: 2027-01-12
Clinical trial
An ObEsity-centric Approach With and Without Anti-obesity Medications ComPared to the Usual-care ApprOach to Management of Patients With Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2022-08-15